Table 4.
Association of eczema phenotypes with combined asthma and physician-diagnosed allergy groups in children at age 10 years
Asthma, but no allergy n = 97 |
Allergy, but no asthma n = 413 |
Asthma and allergy n = 140 |
|
---|---|---|---|
Never eczema | Reference | Reference | Reference |
Ever eczema | 5.83 (3.49, 9.74) | 4.03 (3.17, 5.11) | 8.98 (5.89, 13.69) |
Never | Reference | Reference | Reference |
Early transient | 5.36 (3.07, 9.36) | 3.68 (2.67, 5.08) | 7.11 (4.33, 11.67) |
Mid-transient | 1.37 (0.45, 4.19) | 2.21 (1.47, 3.32) | 4.31 (2.33, 7.99) |
Late transient | 2.94 (1.47, 5.89) | 1.76 (1.18, 2.64) | 3.48 (1.88, 6.44) |
Persistent | 5.23 (1.55, 17.63) | 10.02 (5.92, 16.96) | 29.03 (15.27, 55.22) |
Values are odds ratios (95% confidence intervals) from logistic regression models for never/ever eczema and average odds ratios (95% confidence intervals) from multinomial regression models after multiple sampling based on 150 imputed datasets for eczema phenotypes. Reference group is no asthma and no allergy (n = 3627). n = number of participants with information on at least 3 eczema measurements. Missing data on asthma and physician-diagnosed allergy was imputed. Full models were adjusted for parental history of allergy, asthma or eczema, maternal education, parity, child’s sex, ethnicity and breastfeeding. Italic values indicate statistical significance at the α = 0.05 level